Chikungunya virus: An update on antiviral development and challenges

Drug Discovery Today

Volumn 18, Issue 19-20, 2013, Pages 969-983

  Kaur, Parveen ^a   Chu, Justin Jang Hann ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; APIGENIN; ARBIDOL; AZAURIDINE; CHLOROQUINE; CHLORPROMAZINE; CHRYSIN; HARRINGTONINE; HOMOHARRINGTONINE; METHDILAZINE; MYCOPHENOLIC ACID; NARINGENIN; PERPHENAZINE; PHORBOL 13 ACETATE 12 MYRISTATE; POLYINOSINIC POLYCYTIDYLIC ACID; PROFENAMINE; PROSTRATIN; PROTHIPENDYL; RIBAVIRIN; RNA; SILIBININ; THIETHYLPERAZINE; THIORIDAZINE; TRIGOCHERRIN A; TRIGOCHERRIN B; TRIGOCHERRIOLIDE A; TRIGOCHERRIOLIDE B; TRIGOCHERRIOLIDE C; TRIGOWIN A; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIVIRAL ACTIVITY; CHIKUNGUNYA; CHIKUNGUNYA ALPHAVIRUS; DRUG EFFICACY; DRUG MECHANISM; EPIDEMIC; GENE SILENCING; HOST; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; REVIEW;

ALPHAVIRUS INFECTIONS; ANIMALS; ANTIVIRAL AGENTS; CHIKUNGUNYA VIRUS; DRUG DISCOVERY; HUMANS;

EID: 84884591270     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2013.05.002     Document Type: Review

References (78)

1. M. Sourisseau Characterization of reemerging Chikungunya virus PLoS Pathog. 3 2007 e89
2. A.N.W. Maek, and U. Silachamroon Presence of autoimmune antibody in Chikungunya infection Case Rep. Med. 2009 2009 840183
3. K. Labadie Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages J. Clin. Invest. 120 2010 894 906
4. L. Dupuis-Maguiraga Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia PLoS Negl. Trop. Dis. 6 2012 e1446
5. M.C. Robinson An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features Trans. R. Soc. Trop. Med. Hyg. 49 1955 28 32
6. I. Schuffenecker Genome microevolution of Chikungunya viruses causing the Indian Ocean outbreak PLoS Med. 3 2006 e263
7. S. Robin Neurologic manifestations of pediatric Chikungunya infection J. Child. Neurol. 23 2008 1028 1035
8. D. Mavalankar Increased mortality rate associated with Chikungunya epidemic, Ahmedabad, India Emerg. Infect. Dis. 14 2008 412 415 (Pubitemid 351451388)
9. Y. Lenglet Chikungunya infection in pregnancy: evidence for intrauterine infection in pregnant women and vertical transmission in the parturient, Survey of the Réunion Island outbreak J. Gynecol. Obstet. Biol. Reprod. (Paris) 35 2006 578 583 (Pubitemid 44525498)
10. W.A. Hawley Aedes albopictus in North America: probable introduction in used tires from northern Asia Science 236 1987 1114 1116 (Pubitemid 17113257)
11. H.C. Hapuarachchi Re-emergence of Chikungunya virus in South-east Asia: virological evidence from Sri Lanka and Singapore J. Gen. Virol. 91 2010 1067 1076
12. P. Hochedez Cases of Chikungunya fever imported from the islands of the South West Indian Ocean to Paris, France Euro. Surveill. 12 2007 [Epub]
13. P.L. Lim Chikungunya in Singapore: imported cases among travelers visiting friends and relatives J. Travel Med. 16 2009 289 291
14. M. Pfeffer, and T. Loscher Cases of Chikungunya imported into Europe Euro. Surveill. 11 2006 E060316.2 [Epub]
15. A.C. Brehin The large form of human 2′,5′-oligoadenylate synthetase (OAS3) exerts antiviral effect against Chikungunya virus Virology 384 2009 216 222
16. B. Queyriaux Clinical burden of Chikungunya virus infection Lancet Infect. Dis. 8 2008 2 3 (Pubitemid 351626997)
17. E. Sreekumar Genetic characterization of 2006-2008 isolates of Chikungunya virus from Kerala, South India, by whole genome sequence analysis Virus Genes 40 2010 14 27
18. R.C. Lee Mosquito cellular factors and functions in mediating the infectious entry of Chikungunya virus PLoS Negl. Trop. Dis. 7 2013 e2050
19. E. Bernard Endocytosis of Chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments PLoS ONE 5 2010 e11479
20. A. Helenius On the entry of Semliki forest virus into BHK-21 cells J. Cell Biol. 84 1980 404 420 (Pubitemid 10147875)
21. D.J. Barton Solubilization and immunoprecipitation of alphavirus replication complexes J. Virol. 65 1991 1496 1506
22. G.E. Gifford, and E. Heller Effect of actinomycin D on interferon production by 'active' and 'inactive' Chikungunya virus in chick cells Nature 200 1963 50 51
23. J.H. Strauss, and E.G. Strauss The alphaviruses: gene expression, replication, and evolution Microbiol. Rev. 58 1994 491 562
24. S. Ozden Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein J. Biol. Chem. 283 2008 21899 21908
25. M. Ekstrom Membrane protein lateral interactions control Semliki Forest virus budding EMBO J. 13 1994 1058 1064 (Pubitemid 24074712)
26. E. Teissier Targeting cell entry of enveloped viruses as an antiviral strategy Molecules 16 2011 221 250
27. P. Wintachai Identification of prohibitin as a Chikungunya virus receptor protein J. Med. Virol. 84 2012 1757 1770
28. A. Savarino Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors J. Acquir. Immune Defic. Syndr. 35 2004 223 232 (Pubitemid 38280647)
29. E. Keyaerts In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine Biochem. Biophys. Res. Commun. 323 2004 264 268 (Pubitemid 39200678)
30. A. Helenius Inhibition of Semliki forest virus penetration by lysosomotropic weak bases J. Gen. Virol. 58 1982 47 61 (Pubitemid 12182108)
31. M. Khan Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells J. Med. Virol. 82 2010 817 824
32. X. de Lamballerie Antiviral treatment of Chikungunya virus infection Infect. Disord. Drug Targets. 9 2009 101 104
33. S.W. Brighton Chloroquine phosphate treatment of chronic Chikungunya arthritis. An open pilot study S. Afr. Med. J. 66 1984 217 218 (Pubitemid 14063933)
34. A. Savarino New insights into the antiviral effects of chloroquine Lancet Infect. Dis. 6 2006 67 69 (Pubitemid 43138901)
35. Y.S. Boriskin Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection Virol. J. 3 2006 56
36. I. Delogu In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant Antiviral. Res. 90 2011 99 107
37. J.E. Voss Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography Nature 468 2010 709 712
38. M.Y. Liu Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers Clin. Ther. 31 2009 784 792
39. L. Pohjala Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays PLoS ONE 6 2011 e28923
40. P.K. Dash RNA interference mediated inhibition of Chikungunya virus replication in mammalian cells Biochem. Biophys. Res. Commun. 376 2008 718 722
41. S. Lam Expression of plasmid-based shRNA against the E1 and nsP1 genes effectively silenced Chikungunya virus replication PLoS ONE 7 2012 e46396
42. T.C. Karagiannis, and A. El-Osta RNA interference and potential therapeutic applications of short interfering RNAs Cancer Gene Ther. 12 2005 787 795 (Pubitemid 43086280)
43. P. Kaur Inhibition of Chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression Antimicrob. Agents Chemother. 57 2013 155 167
44. M. Fresno Inhibition of translation in eukaryotic systems by harringtonine Eur. J. Biochem. 72 1977 323 330 (Pubitemid 8022231)
45. T.L. Jiang Comparative in vitro antitumor activity of homoharringtonine and harringtonine against clonogenic human tumor cells Invest. New Drugs 1 1983 21 25 (Pubitemid 14117517)
46. C.J. Weng, and G.C. Yen Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities Cancer Metast. Rev. 31 2012 323 351
47. P.M. Allard Antiviral chlorinated daphnane diterpenoid orthoesters from the bark and wood of Trigonostemon cherrieri Phytochemistry 84 2012 160 168
48. M. Bourai Mapping of Chikungunya virus interactions with host proteins identified nsP2 as a highly connected viral component J. Virol. 86 2012 3121 3134
49. J.J. Fros Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling J. Virol. 84 2010 10877 10887
50. I. Akhrymuk Evasion of the innate immune response: the Old World alphavirus nsP2 protein induces rapid degradation of Rpb1, a catalytic subunit of RNA polymerase II J. Virol. 86 2012 7180 7191
51. M. Lucas-Hourani A phenotypic assay to identify Chikungunya virus inhibitors targeting the nonstructural protein nsP2 J. Biomol. Screen. 18 2013 172 179
52. M. Bassetto Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against Chikungunya virus Antiviral Res. 98 2013 12 18
53. J.D. Graci, and C.E. Cameron Mechanisms of action of ribavirin against distinct viruses Rev. Med. Virol. 16 2006 37 48 (Pubitemid 43133592)
54. A.C. Cooper Management and prevention strategies for respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a review of evidence-based practice interventions Pediatr. Nurs. 29 2003 452 456
55. T. Poynard Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus, International Hepatitis Interventional Therapy Group (IHIT) Lancet 352 1998 1426 1432 (Pubitemid 28510876)
56. A. Mangia Individualized treatment duration for hepatitis C genotype 1 patients: a randomized controlled trial Hepatology 47 2008 43 50 (Pubitemid 351171040)
57. S. Briolant In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-α and ribavirin combination Antiviral Res. 61 2004 111 117 (Pubitemid 37506098)
58. R. Ravichandran, and M. Manian Ribavirin therapy for Chikungunya arthritis J. Infect. Dev. Ctries 2 2008 140 142
59. M. Khan Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells Antiviral Res. 89 2011 1 8
60. L.M. Scheidel, and V. Stollar Mutations that confer resistance to mycophenolic acid and ribavirin on Sindbis virus map to the nonstructural protein nsP1 Virology 181 1991 490 499
61. B. Rada, and M. Dragun Antiviral action and selectivity of 6-azauridine Ann. N. Y. Acad. Sci. 284 1977 410 417
62. R.J. Klein Herpes simplex virus skin infection in hairless mice: treatment with antiviral compounds Antimicrob. Agents Chemother. 5 1974 318 322
63. J. Cinatl Jr. Development of antiviral therapy for severe acute respiratory syndrome Antiviral Res. 66 2005 81 97 (Pubitemid 40720113)
64. J.J. Lipsky Mycophenolate mofetil Lancet 348 1996 1357 1359 (Pubitemid 26383778)
65. O. Schwartz, and M.L. Albert Biology and pathogenesis of Chikungunya virus Nat. Rev. Microbiol. 8 2010 491 500
66. A. Chow Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor J. Infect. Dis. 203 2011 149 157
67. M.J. de Veer Functional classification of interferon-stimulated genes identified using microarrays J. Leukoc. Biol. 69 2001 912 920 (Pubitemid 32577892)
68. F.B. Grieder, and S.N. Vogel Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection Virology 257 1999 106 118 (Pubitemid 29391805)
69. A.J. Pinto Comparative therapeutic efficacy of recombinant interferons-alpha, -beta, and -gamma against alphatogavirus, bunyavirus, flavivirus, and herpesvirus infections J. Interferon Res. 10 1990 293 298 (Pubitemid 20186219)
70. K.D. Ryman Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism J. Virol. 74 2000 3366 3378 (Pubitemid 30143762)
71. L. Bordi Chikungunya virus isolates with/without A226V mutation show different sensitivity to IFN-a, but similar replication kinetics in non human primate cells New Microbiol. 34 2011 87 91
72. A.K. Field Inducers of interferon and host resistance, II. Multistranded synthetic polynucleotide complexes Proc. Natl. Acad. Sci. U. S. A. 58 1967 1004 1010
73. Y.G. Li Poly (I:C), an agonist of Toll-like receptor-3, inhibits replication of the Chikungunya virus in BEAS-2B cells Virol. J. 9 2012 114
74. T. Ichinohe Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection J. Virol. 79 2005 2910 2919 (Pubitemid 40270569)
75. T. Ichinohe PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants Vaccine 27 2009 6276 6279
76. M. Bourjot Prostratin and 12-O-tetradecanoylphorbol 13-acetate are potent and selective inhibitors of Chikungunya virus replication J. Nat. Prod. 75 2012 2183 2187
77. I.H. Chowdhury The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: possible involvement of protein kinase C pathway Virology 176 1990 126 132
78. G. Nabel, and D. Baltimore An inducible transcription factor activates expression of human immunodeficiency virus in T cells Nature 326 1987 711 713 (Pubitemid 17059793)